During the CBS Democratic debate on Saturday, November 14, 2015, former Secretary of State Hillary Clinton tried to use the tragedy of 9/11 as a political excuse for her coziness with Wall Street interests, including the millions she has received in Wall Street campaign funding over her career. That defense of the Clinton campaign’s corporate fundraising has been widely assailed in the media and on social media. In an attempt to divert the public’s gaze from Wall Street coziness, the Clinton campaign has launched a false attack on universal health care – something she has previously supported. The Clinton campaign received more contributions from the pharmaceutical industry than any other – Republican or Democrat – through the first six months of the campaign. So, what is this false attack really all about: either Secretary Hillary Clinton is repudiating years of advocating for universal health or she’s playing politics with the health of America’s families.
 
It’s hard to understand how someone who claims to have been a supporter of universal health insurance for years is suddenly moving to the right and attacking universal health care. Or, maybe it’s not:
 
The Clinton campaign received far more money from the drug and medical device industries than any other presidential candidate in either party during the first six months of the campaign, according to figures compiled by the Center for Responsive Politics. She accepted $164,315 during that period.
 
[…]
 
At the same time, she has accepted significant contributions from individual donors. She received contributions, for example, from two executives at Jazz Pharmaceuticals, which raised the price of a drug used to treat sleep disorders by more than 800 percent, from roughly $2 to $19 a pill.